ID   DHAS_ECOLI              Reviewed;         367 AA.
AC   P0A9Q9; P00353; Q2M797;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   15-MAR-2017, entry version 109.
DE   RecName: Full=Aspartate-semialdehyde dehydrogenase {ECO:0000255|HAMAP-Rule:MF_02121};
DE            Short=ASA dehydrogenase {ECO:0000255|HAMAP-Rule:MF_02121};
DE            Short=ASADH {ECO:0000255|HAMAP-Rule:MF_02121};
DE            EC=1.2.1.11 {ECO:0000269|PubMed:11368768, ECO:0000269|PubMed:6102909};
DE   AltName: Full=Aspartate-beta-semialdehyde dehydrogenase {ECO:0000255|HAMAP-Rule:MF_02121};
GN   Name=asd {ECO:0000255|HAMAP-Rule:MF_02121}; Synonyms=hom;
GN   OrderedLocusNames=b3433, JW3396;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=6143662;
RA   Haziza C., Stragier P., Patte J.-C.;
RT   "Nucleotide sequence of the asd gene of Escherichia coli: absence of a
RT   typical attenuation signal.";
RL   EMBO J. 1:379-384(1982).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   PROTEIN SEQUENCE OF 1-5, FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RC   STRAIN=K12;
RX   PubMed=6102909; DOI=10.1111/j.1432-1033.1980.tb04398.x;
RA   Biellmann J.F., Eid P., Hirth C., Jornvall H.;
RT   "Aspartate-beta-semialdehyde dehydrogenase from Escherichia coli.
RT   Purification and general properties.";
RL   Eur. J. Biochem. 104:53-58(1980).
RN   [5]
RP   PROTEIN SEQUENCE OF 1-12.
RC   STRAIN=K12 / EMG2;
RX   PubMed=9298646; DOI=10.1002/elps.1150180807;
RA   Link A.J., Robison K., Church G.M.;
RT   "Comparing the predicted and observed properties of proteins encoded
RT   in the genome of Escherichia coli K-12.";
RL   Electrophoresis 18:1259-1313(1997).
RN   [6]
RP   ACTIVE SITE, AND MUTAGENESIS OF CYS-135.
RX   PubMed=1350921; DOI=10.1016/0167-4838(92)90360-P;
RA   Karsten W.E., Viola R.E.;
RT   "Identification of an essential cysteine in the reaction catalyzed by
RT   aspartate-beta-semialdehyde dehydrogenase from Escherichia coli.";
RL   Biochim. Biophys. Acta 1121:234-238(1992).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, AND KINETIC PARAMETERS.
RX   PubMed=11368768; DOI=10.1042/0264-6021:3560415;
RA   Chassagnole C., Rais B., Quentin E., Fell D.A., Mazat J.P.;
RT   "An integrated study of threonine-pathway enzyme kinetics in
RT   Escherichia coli.";
RL   Biochem. J. 356:415-423(2001).
RN   [8]
RP   ENZYME REGULATION, AND INHIBITION BY CYSTEINE BINDING AT CYS-135.
RX   PubMed=14726201; DOI=10.1016/j.bbapap.2003.09.002;
RA   Alvarez E., Ramon F., Magan C., Diez E.;
RT   "L-cystine inhibits aspartate-beta-semialdehyde dehydrogenase by
RT   covalently binding to the essential 135Cys of the enzyme.";
RL   Biochim. Biophys. Acta 1696:23-29(2004).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS), AND DOMAIN.
RX   PubMed=10369777; DOI=10.1006/jmbi.1999.2828;
RA   Hadfield A., Kryger G., Ouyang J., Petsko G.A., Ringe D., Viola R.;
RT   "Structure of aspartate-beta-semialdehyde dehydrogenase from
RT   Escherichia coli, a key enzyme in the aspartate family of amino acid
RT   biosynthesis.";
RL   J. Mol. Biol. 289:991-1002(1999).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) IN COMPLEX WITH CYSTEINE AND
RP   NADP, ACTIVE SITE, AND CATALYTIC MECHANISM.
RX   PubMed=11724560; DOI=10.1021/bi015713o;
RA   Hadfield A., Shammas C., Kryger G., Ringe D., Petsko G.A., Ouyang J.,
RA   Viola R.E.;
RT   "Active site analysis of the potential antimicrobial target aspartate
RT   semialdehyde dehydrogenase.";
RL   Biochemistry 40:14475-14483(2001).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (1.6 ANGSTROMS) OF MUTANT GLN-2.
RX   PubMed=15288787; DOI=10.1016/j.jmb.2004.05.073;
RA   Nichols C.E., Dhaliwal B., Lockyer M., Hawkins A.R., Stammers D.K.;
RT   "High-resolution structures reveal details of domain closure and
RT   'half-of-sites-reactivity' in Escherichia coli aspartate beta-
RT   semialdehyde dehydrogenase.";
RL   J. Mol. Biol. 341:797-806(2004).
CC   -!- FUNCTION: Catalyzes the NADPH-dependent formation of L-aspartate-
CC       semialdehyde (L-ASA) by the reductive dephosphorylation of L-
CC       aspartyl-4-phosphate. {ECO:0000269|PubMed:11368768,
CC       ECO:0000269|PubMed:6102909}.
CC   -!- CATALYTIC ACTIVITY: L-aspartate 4-semialdehyde + phosphate +
CC       NADP(+) = L-4-aspartyl phosphate + NADPH.
CC       {ECO:0000269|PubMed:11368768, ECO:0000269|PubMed:6102909}.
CC   -!- ENZYME REGULATION: Is inhibited by L- and D-cystine, and by other
CC       cystine derivatives, via the formation of a covalently bound
CC       cysteine at the active site Cys-135.
CC       {ECO:0000269|PubMed:14726201}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=22 uM for L-4-aspartyl phosphate
CC         {ECO:0000269|PubMed:11368768};
CC         KM=29 uM for NADPH {ECO:0000269|PubMed:11368768};
CC         KM=110 uM for L-aspartate 4-semialdehyde
CC         {ECO:0000269|PubMed:11368768};
CC         KM=144 uM for NADP(+) {ECO:0000269|PubMed:11368768};
CC         KM=10.2 mM for phosphate {ECO:0000269|PubMed:11368768};
CC   -!- PATHWAY: Amino-acid biosynthesis; L-lysine biosynthesis via DAP
CC       pathway; (S)-tetrahydrodipicolinate from L-aspartate: step 2/4.
CC       {ECO:0000255|HAMAP-Rule:MF_02121}.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-methionine biosynthesis via de
CC       novo pathway; L-homoserine from L-aspartate: step 2/3.
CC       {ECO:0000255|HAMAP-Rule:MF_02121}.
CC   -!- PATHWAY: Amino-acid biosynthesis; L-threonine biosynthesis; L-
CC       threonine from L-aspartate: step 2/5. {ECO:0000255|HAMAP-
CC       Rule:MF_02121}.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:11724560,
CC       ECO:0000269|PubMed:6102909}.
CC   -!- DOMAIN: Consists of two domains, an N-terminal nucleotide-binding
CC       domain and a C-terminal dimerization domain.
CC       {ECO:0000269|PubMed:10369777}.
CC   -!- SIMILARITY: Belongs to the aspartate-semialdehyde dehydrogenase
CC       family. {ECO:0000255|HAMAP-Rule:MF_02121}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; V00262; CAA23511.1; -; Genomic_DNA.
DR   EMBL; U18997; AAA58231.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC76458.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAE77859.1; -; Genomic_DNA.
DR   PIR; A00364; DEECDA.
DR   RefSeq; NP_417891.1; NC_000913.3.
DR   RefSeq; WP_000799956.1; NZ_LN832404.1.
DR   PDB; 1BRM; X-ray; 2.50 A; A/B/C=1-367.
DR   PDB; 1GL3; X-ray; 2.60 A; A/B=1-367.
DR   PDB; 1T4B; X-ray; 1.60 A; A/B=1-367.
DR   PDB; 1T4D; X-ray; 1.95 A; A/B/C=1-367.
DR   PDBsum; 1BRM; -.
DR   PDBsum; 1GL3; -.
DR   PDBsum; 1T4B; -.
DR   PDBsum; 1T4D; -.
DR   ProteinModelPortal; P0A9Q9; -.
DR   SMR; P0A9Q9; -.
DR   IntAct; P0A9Q9; 1.
DR   STRING; 511145.b3433; -.
DR   SWISS-2DPAGE; P0A9Q9; -.
DR   EPD; P0A9Q9; -.
DR   PaxDb; P0A9Q9; -.
DR   PRIDE; P0A9Q9; -.
DR   EnsemblBacteria; AAC76458; AAC76458; b3433.
DR   EnsemblBacteria; BAE77859; BAE77859; BAE77859.
DR   GeneID; 947939; -.
DR   KEGG; ecj:JW3396; -.
DR   KEGG; eco:b3433; -.
DR   PATRIC; 32122306; VBIEscCol129921_3530.
DR   EchoBASE; EB0086; -.
DR   EcoGene; EG10088; asd.
DR   eggNOG; ENOG4105CM3; Bacteria.
DR   eggNOG; COG0136; LUCA.
DR   HOGENOM; HOG000161376; -.
DR   InParanoid; P0A9Q9; -.
DR   KO; K00133; -.
DR   OMA; SCQGGDY; -.
DR   PhylomeDB; P0A9Q9; -.
DR   BioCyc; EcoCyc:ASP-SEMIALDEHYDE-DEHYDROGENASE-MONOMER; -.
DR   BioCyc; MetaCyc:ASP-SEMIALDEHYDE-DEHYDROGENASE-MONOMER; -.
DR   BRENDA; 1.2.1.11; 2026.
DR   UniPathway; UPA00034; UER00016.
DR   UniPathway; UPA00050; UER00463.
DR   UniPathway; UPA00051; UER00464.
DR   EvolutionaryTrace; P0A9Q9; -.
DR   PRO; PR:P0A9Q9; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0004073; F:aspartate-semialdehyde dehydrogenase activity; IDA:EcoCyc.
DR   GO; GO:0003942; F:N-acetyl-gamma-glutamyl-phosphate reductase activity; IEA:InterPro.
DR   GO; GO:0051287; F:NAD binding; IEA:InterPro.
DR   GO; GO:0050661; F:NADP binding; IEA:InterPro.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEP:EcoliWiki.
DR   GO; GO:0019877; P:diaminopimelate biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009090; P:homoserine biosynthetic process; IDA:EcoCyc.
DR   GO; GO:0009097; P:isoleucine biosynthetic process; IEA:InterPro.
DR   GO; GO:0009089; P:lysine biosynthetic process via diaminopimelate; IDA:EcoCyc.
DR   GO; GO:0009086; P:methionine biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009088; P:threonine biosynthetic process; IEA:UniProtKB-UniPathway.
DR   Gene3D; 3.40.50.720; -; 1.
DR   HAMAP; MF_02121; ASADH; 1.
DR   InterPro; IPR000319; Asp-semialdehyde_DH_CS.
DR   InterPro; IPR011534; Asp_ADH_gamma-type.
DR   InterPro; IPR012080; Asp_semialdehyde_DH.
DR   InterPro; IPR016040; NAD(P)-bd_dom.
DR   InterPro; IPR000534; Semialdehyde_DH_NAD-bd.
DR   InterPro; IPR012280; Semialdhyde_DH_dimer_dom.
DR   PANTHER; PTHR10174:SF194; PTHR10174:SF194; 1.
DR   Pfam; PF01118; Semialdhyde_dh; 1.
DR   Pfam; PF02774; Semialdhyde_dhC; 1.
DR   PIRSF; PIRSF000148; ASA_dh; 1.
DR   SMART; SM00859; Semialdhyde_dh; 1.
DR   SUPFAM; SSF51735; SSF51735; 1.
DR   TIGRFAMs; TIGR01745; asd_gamma; 1.
DR   PROSITE; PS01103; ASD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Amino-acid biosynthesis; Complete proteome;
KW   Diaminopimelate biosynthesis; Direct protein sequencing;
KW   Lysine biosynthesis; Methionine biosynthesis; NADP; Oxidoreductase;
KW   Reference proteome; Threonine biosynthesis.
FT   CHAIN         1    367       Aspartate-semialdehyde dehydrogenase.
FT                                /FTId=PRO_0000141369.
FT   NP_BIND      10     13       NADP. {ECO:0000269|PubMed:11724560}.
FT   NP_BIND      37     38       NADP. {ECO:0000269|PubMed:11724560}.
FT   NP_BIND     165    169       NADP. {ECO:0000269|PubMed:11724560}.
FT   ACT_SITE    135    135       Acyl-thioester intermediate.
FT                                {ECO:0000269|PubMed:11724560}.
FT   ACT_SITE    274    274       Proton acceptor.
FT                                {ECO:0000305|PubMed:11724560}.
FT   BINDING      73     73       NADP. {ECO:0000269|PubMed:11724560}.
FT   BINDING     102    102       Phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02121}.
FT   BINDING     162    162       Substrate. {ECO:0000305|PubMed:11724560}.
FT   BINDING     173    173       NADP. {ECO:0000269|PubMed:11724560}.
FT   BINDING     193    193       NADP; via carbonyl oxygen.
FT                                {ECO:0000269|PubMed:11724560}.
FT   BINDING     241    241       Substrate. {ECO:0000305|PubMed:11724560}.
FT   BINDING     244    244       Phosphate. {ECO:0000255|HAMAP-
FT                                Rule:MF_02121}.
FT   BINDING     267    267       Substrate. {ECO:0000305|PubMed:11724560}.
FT   BINDING     350    350       NADP. {ECO:0000269|PubMed:11724560}.
FT   MOD_RES     135    135       S-cysteinyl cysteine; in inhibited form.
FT   MUTAGEN     135    135       C->A: Complete loss of activity.
FT                                {ECO:0000269|PubMed:1350921}.
FT   MUTAGEN     135    135       C->S: 99.7% loss of activity.
FT                                {ECO:0000269|PubMed:1350921}.
FT   CONFLICT      9      9       W -> G (in Ref. 5; AA sequence).
FT                                {ECO:0000305}.
FT   STRAND        3      8       {ECO:0000244|PDB:1T4B}.
FT   HELIX        12     23       {ECO:0000244|PDB:1T4B}.
FT   HELIX        26     29       {ECO:0000244|PDB:1T4B}.
FT   STRAND       30     39       {ECO:0000244|PDB:1T4B}.
FT   STRAND       41     43       {ECO:0000244|PDB:1T4D}.
FT   HELIX        46     48       {ECO:0000244|PDB:1T4B}.
FT   HELIX        60     64       {ECO:0000244|PDB:1T4B}.
FT   STRAND       67     71       {ECO:0000244|PDB:1T4B}.
FT   HELIX        75     87       {ECO:0000244|PDB:1T4B}.
FT   STRAND       93     96       {ECO:0000244|PDB:1T4B}.
FT   TURN        100    103       {ECO:0000244|PDB:1T4B}.
FT   STRAND      107    110       {ECO:0000244|PDB:1T4B}.
FT   HELIX       112    124       {ECO:0000244|PDB:1T4B}.
FT   STRAND      129    132       {ECO:0000244|PDB:1T4B}.
FT   HELIX       135    149       {ECO:0000244|PDB:1T4B}.
FT   STRAND      153    162       {ECO:0000244|PDB:1T4B}.
FT   HELIX       164    166       {ECO:0000244|PDB:1T4B}.
FT   HELIX       169    185       {ECO:0000244|PDB:1T4B}.
FT   HELIX       187    190       {ECO:0000244|PDB:1T4B}.
FT   HELIX       197    210       {ECO:0000244|PDB:1T4B}.
FT   TURN        216    218       {ECO:0000244|PDB:1T4B}.
FT   STRAND      226    228       {ECO:0000244|PDB:1T4B}.
FT   STRAND      235    239       {ECO:0000244|PDB:1GL3}.
FT   HELIX       240    253       {ECO:0000244|PDB:1T4B}.
FT   STRAND      261    264       {ECO:0000244|PDB:1T4B}.
FT   STRAND      267    269       {ECO:0000244|PDB:1T4B}.
FT   STRAND      271    284       {ECO:0000244|PDB:1T4B}.
FT   HELIX       288    298       {ECO:0000244|PDB:1T4B}.
FT   STRAND      302    304       {ECO:0000244|PDB:1GL3}.
FT   HELIX       309    315       {ECO:0000244|PDB:1T4B}.
FT   HELIX       318    321       {ECO:0000244|PDB:1T4B}.
FT   STRAND      329    334       {ECO:0000244|PDB:1T4B}.
FT   STRAND      341    349       {ECO:0000244|PDB:1T4B}.
FT   HELIX       352    356       {ECO:0000244|PDB:1T4B}.
FT   HELIX       357    366       {ECO:0000244|PDB:1T4B}.
SQ   SEQUENCE   367 AA;  40018 MW;  F53D4C36EA7CC201 CRC64;
     MKNVGFIGWR GMVGSVLMQR MVEERDFDAI RPVFFSTSQL GQAAPSFGGT TGTLQDAFDL
     EALKALDIIV TCQGGDYTNE IYPKLRESGW QGYWIDAASS LRMKDDAIII LDPVNQDVIT
     DGLNNGIRTF VGGNCTVSLM LMSLGGLFAN DLVDWVSVAT YQAASGGGAR HMRELLTQMG
     HLYGHVADEL ATPSSAILDI ERKVTTLTRS GELPVDNFGV PLAGSLIPWI DKQLDNGQSR
     EEWKGQAETN KILNTSSVIP VDGLCVRVGA LRCHSQAFTI KLKKDVSIPT VEELLAAHNP
     WAKVVPNDRE ITMRELTPAA VTGTLTTPVG RLRKLNMGPE FLSAFTVGDQ LLWGAAEPLR
     RMLRQLA
//
